CSPC Pharmaceutical Group Ltd (CSPCY)
3.17
-0.05
(-1.55%)
USD |
OTCM |
Jun 21, 16:00
CSPC Pharmaceutical Group Revenue (Quarterly): 1.054B for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.054B |
September 30, 2023 | 1.076B |
June 30, 2023 | 1.145B |
March 31, 2023 | 1.177B |
Date | Value |
---|---|
December 31, 2022 | 1.046B |
September 30, 2022 | 1.151B |
June 30, 2022 | 1.170B |
March 31, 2022 | 1.239B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.046B
Minimum
Dec 2022
1.239B
Maximum
Mar 2022
1.132B
Average
1.148B
Median
Revenue (Quarterly) Benchmarks
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | 3.409M |
Zai Lab Ltd | 87.15M |
Adagene Inc | -- |
LakeShore Biopharma Co Ltd | 13.38M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 191.54M |
Total Expenses (Quarterly) | 805.15M |
EPS Diluted (Quarterly) | 0.0646 |
Enterprise Value | 7.900B |
Gross Profit Margin (Quarterly) | 70.99% |
Profit Margin (Quarterly) | 18.18% |
Earnings Yield | 8.83% |
Operating Earnings Yield | 10.54% |
Normalized Earnings Yield | 8.828 |